| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/20/2007 | CA2186784C The use of carboxylic acid derivatives as drugs |
| 02/15/2007 | WO2007019417A1 Oxazolopyridine derivatives as sirtuin modulators |
| 02/15/2007 | WO2007018248A1 Pyridone compound |
| 02/15/2007 | WO2007018137A1 Multikinase inhibitor |
| 02/15/2007 | WO2007017713A1 The substance having antioxidant, geroprotective and anti-ischemic activity and method for preparing thereof |
| 02/15/2007 | WO2007017505A2 Treatment of metabolic diseases |
| 02/15/2007 | WO2007017469A2 Process for preparing an angiotensin ii receptor antagonist |
| 02/15/2007 | WO2007017436A2 Method for the protection against the risk of cardiac disorders comprising administration of tiotropium salts |
| 02/15/2007 | WO2007017265A1 Xanthine derivatives as selective hm74a agonists |
| 02/15/2007 | WO2007017262A1 Xanthine derivatives as selective hm74a agonists |
| 02/15/2007 | WO2007017261A1 Xanthine derivatives as selective hm74a agonists |
| 02/15/2007 | WO2007017125A1 Cb1 antagonists or inverse antagonists as therapeutical agents for the treatment of inflammation involving gene expression |
| 02/15/2007 | WO2007017087A1 Process for the preparation of crystalline perindopril |
| 02/15/2007 | WO2007016784A1 Novel substituted 1,2,3-tπazolylmethyl-benzothiophene or -indole and their use as leukotπene biosynthesis inhibitors |
| 02/15/2007 | WO2007016777A1 Targeted protein kinase c inhibitors and uses thereof |
| 02/15/2007 | WO2006125180B1 Piperazine derivatives and their uses as therapeutic agents |
| 02/15/2007 | WO2006105838A3 Use of a combination of vitamins b and phytosterols for lowering blood pressure |
| 02/15/2007 | US20070037996 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 02/15/2007 | US20070037995 A Substantially Cell Membrane Impermeable Compound And Use Thereof |
| 02/15/2007 | US20070037883 Therapeutic compositions |
| 02/15/2007 | US20070037882 Remedy for cerebral neurodegenerative diseases using ppar agonist |
| 02/15/2007 | US20070037879 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/15/2007 | US20070037878 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/15/2007 | US20070037864 Intermediates for the preparation of lipoxin A4 analogs |
| 02/15/2007 | US20070037813 Serine Protease Inhibitors |
| 02/15/2007 | US20070037749 Administering a N-terminus modified polypeptide derived from the fibrin alpha or beta chain; antiinflammatory agent, anticoagulants; transplant rejection; arteriosclerosis |
| 02/15/2007 | US20070036860 Treatment of allergic conditions |
| 02/15/2007 | US20070036854 Therapeutic applications of pro-apoptotic benzodiazepines |
| 02/15/2007 | US20070036813 Expression vector comprising nucleotide sequences coding endothelial growth factor protein for use in prevention and treatment of cell proliferative and eye disorders |
| 02/15/2007 | US20070036794 Agonist anti-trkC monoclonal antibodies, directed against epitopes in extracellular domain of trkC receptor, which mimic biological activities of NT-3, the natural ligand of trkC receptor, but are free of some of known detriments of NT-3; use of theseagonist antibodies treatment of neuropathy |
| 02/15/2007 | US20070036784 Medicament for the protection against thrombotic diseases |
| 02/15/2007 | US20070036780 Modified proteins, designer toxins, and methods of making thereof |
| 02/15/2007 | US20070036768 Systems and methods for treating patients with processed lipoaspirate cells |
| 02/15/2007 | US20070036756 Method for treating ischemic diseases |
| 02/15/2007 | DE102005037733A1 Adeninderivate Adenine derivatives |
| 02/15/2007 | CA2659961A1 Targeted protein kinase c inhibitors and uses thereof |
| 02/15/2007 | CA2626723A1 Xanthine derivatives as selective hm74a agonists |
| 02/15/2007 | CA2618963A1 Xanthine derivatives as selective hm74a agonists |
| 02/15/2007 | CA2618586A1 Novel substituted 1,2,3-triazolylmethyl-benzothiophene or -indole and their use as leukotriene biosynthesis inhibitors |
| 02/15/2007 | CA2618370A1 Oxazolopyridine derivatives as sirtuin modulators |
| 02/15/2007 | CA2618112A1 Pyridone compound |
| 02/15/2007 | CA2617289A1 Process for preparing an angiotensin ii receptor antagonist |
| 02/15/2007 | CA2617101A1 Method for the protection against the risk of cardiac disorders comprising administration of tiotropium salts |
| 02/15/2007 | CA2616451A1 Substituted benzyl derivatives as gsk-3 inhibitors |
| 02/15/2007 | CA2615691A1 Process for the preparation of crystalline perindopril |
| 02/15/2007 | CA2614857A1 Substance having antioxidant, geroprotective and anti-ischemic activity and method for the preparation thereof |
| 02/14/2007 | EP1752538A1 Human bikunin |
| 02/14/2007 | EP1752445A1 New crystalline form III of agometalin, the process for its preparation and pharmaceutical compositions containing it |
| 02/14/2007 | EP1752444A1 New crystalline form IV of agometaline, the process for making it and pharmaceutical compositions containing it |
| 02/14/2007 | EP1752443A1 New crystalline form V of agometaline, the process for its preparation and the pharmaceutical compositions containing it |
| 02/14/2007 | EP1752149A1 CB1 Antagonists or inverse agonists as therapeutical agents for the treatment of inflammation involving gene expression |
| 02/14/2007 | EP1752144A1 Agent for preventing/amelioratig life style-relaetd diseases containing turmeric essential oil component |
| 02/14/2007 | EP1751153A1 Hetaryloxy-substituted phenylamino pyrimidines as rho kinase inhibitors |
| 02/14/2007 | EP1751144A1 Constrained himbacine analogs as thrombin receptor antagonists |
| 02/14/2007 | EP1751140A1 Crystalline forms of a pyridinyl-sulfonamide and their use as endothelin receptor antagonists |
| 02/14/2007 | EP1751133A2 Compositions useful as inhibitors of rock and other protein kinases |
| 02/14/2007 | EP1750805A2 Pyrroloquinoline quinone drugs for treatment of cardiac injury |
| 02/14/2007 | EP1750730A2 Treatment of hypercholesterolemia, hypertriglyceridemia and cardiovascular-related conditions using phosphalipase-a2 inhibitors |
| 02/14/2007 | EP1750723A1 Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
| 02/14/2007 | EP1750712A2 Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions |
| 02/14/2007 | EP1750701A1 Amorphous clopidogrel hydrochloride and its antithrombotic use |
| 02/14/2007 | EP1750699A2 Treatment of diet-related conditions using phospholipase-a2 inhibitors comprising indoles and related compounds |
| 02/14/2007 | EP1750669A1 Solid pharmaceutical form comprising an ltb4 antagonist |
| 02/14/2007 | EP1560828B9 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 02/14/2007 | EP1534391B1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 02/14/2007 | EP1533292B1 Dibenzylamine compound and medicinal use thereof |
| 02/14/2007 | EP1532121B1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives |
| 02/14/2007 | EP1507514B1 Controlled release compositions of estradiol metabolites |
| 02/14/2007 | EP1496909B1 Combination therapy for the treatment of cancer |
| 02/14/2007 | EP1417228B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2007 | EP1395554B1 Substituted carbazoles as inhibitors of spla2 |
| 02/14/2007 | EP1370552B1 Rho-kinase inhibitors |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | EP1343876B1 Modulators of activity of g-protein-coupled receptor kinases |
| 02/14/2007 | EP1343757B1 Indole derivatives |
| 02/14/2007 | EP1339701B1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 02/14/2007 | EP1299378B1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 02/14/2007 | EP1296961B1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 02/14/2007 | EP1278763B1 3-nitrogen-6,7-dioxygen steroids and uses related thereto |
| 02/14/2007 | EP1259234B9 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 02/14/2007 | EP1242452B1 Chimeric natriuretic peptides |
| 02/14/2007 | EP1128813B1 An inhalation system |
| 02/14/2007 | EP1126836B1 Benzamide potassium channel inhibitors |
| 02/14/2007 | EP1124959B1 Cell surface molecule-induced macrophage activation |
| 02/14/2007 | CN1914195A Substituted quinoline compounds |
| 02/14/2007 | CN1914194A Therapeutic agent for vasospasm accompanying bypass operation |
| 02/14/2007 | CN1914169A Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors |
| 02/14/2007 | CN1914151A Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors |
| 02/14/2007 | CN1913894A Remedy for hypertension |
| 02/14/2007 | CN1913881A Preventive and/or therapeutic agent for chronic cerebral circulatory failure |
| 02/14/2007 | CN1911931A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 02/14/2007 | CN1911930A Chemokine receptor anagonists, methods and use therefor |
| 02/14/2007 | CN1911927A Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf alpha levels |
| 02/14/2007 | CN1911924A Extraction method of Nepal eagle tail isoflavone, its derivative and medicipal composition using said derivative as active component |
| 02/14/2007 | CN1911913A New neuropeptide YY5 receptor antagonists |
| 02/14/2007 | CN1911443A Vaccine composition comprising tumor antigen and adjunvant composition |
| 02/14/2007 | CN1911439A Orally administered peptides to ameliorate atherosclerosis |
| 02/14/2007 | CN1911438A 血管新生诱导剂 Angiogenic inducer |
| 02/14/2007 | CN1911429A Medicine contg. irbesartan |
| 02/14/2007 | CN1911428A Medicine for treating hypertension |